v3.26.1
Consolidated Statements of Change in Stockholders’ Deficit - USD ($)
Preferred stock
Common stock
Additional paid in capital
Accumulated Deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2023 $ 74 $ 1,528,926 $ (8,247,862) $ (1,075) $ (6,719,937)
Balance (in Shares) at Dec. 31, 2023 742,416        
Issuance of shares upon the reverse recapitalization $ 13 (2,833,487) (2,833,474)
Issuance of shares upon the reverse recapitalization (in Shares)   134,476        
Additional shares issued in connection with reverse recapitalization $ 1 (1)
Additional shares issued in connection with reverse recapitalization (in Shares)   5,114        
Stock compensation expense $ 10 1,413,448 1,413,458
Stock compensation expense (in Shares)   101,091        
Shares to be issued for stock compensation $ (8) 8
Shares to be issued for stock compensation (in Shares)   (82,757)        
Shares and warrants issued through private placement $ 1 58,089 58,090
Shares and warrants issued through private placement (in Shares)   6,000        
Shares and warrants issued through July public offering $ 17 1,003,983 1,004,000
Shares and warrants issued through July public offering (in Shares)   166,667        
Forgiveness of related party’s debt 2,135,573 2,135,573
Shares and warrants issued through November public offering $ 84 2,304,869 2,304,953
Shares and warrants issued through November public offering (in Shares)   837,788        
Shares issued through warrants exercises $ 48 261,495 261,543
Shares issued through warrants exercises (in Shares)   477,659        
Shares issued through November Pre-funded warrants exercises $ 6 189,884 189,890
Shares issued through November Pre-funded warrants exercises (in Shares)   56,667        
Shares issued through debt-to-equity conversion $ 57 1,499,943 1,500,000
Shares issued through debt-to-equity conversion (in Shares)   568,182        
Shares to be issued for debt-to-equity conversion $ (57) 57
Shares to be issued for debt-to-equity conversion (in Shares)   (568,182)        
Additional round up shares issued due to 1-for-30 reverse stock split
Additional round up shares issued due to 1-for-30 reverse stock split (in Shares)   243        
Foreign currency translation adjustments 94 94
Net loss (13,653,340) (13,653,340)
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 2,445,364        
Preferred stock issued for asset acquisition $ 1 9,415,633 9,415,634
Preferred stock issued for asset acquisition (in Shares) 14,500          
Stock compensation expense $ 153 341,309 341,462
Stock compensation expense (in Shares)   1,525,590        
Shares to be issued for stock compensation $ (100) 100
Shares to be issued for stock compensation (in Shares)   (1,000,834)        
Shares issued through warrants exercises $ 184 865,239 865,423
Shares issued through warrants exercises (in Shares)   1,839,023        
Shares issued through debt-to-equity conversion $ 1,384 1,715,746 1,717,130
Shares issued through debt-to-equity conversion (in Shares)   13,841,623        
Shares issued through convertible notes conversion $ 1,103 1,021,344 1,022,447
Shares issued through convertible notes conversion (in Shares)   11,028,705        
Shares issued through preferred shares conversion $ (1) $ 8,120 47,081 55,200
Shares issued through preferred shares conversion (in Shares) (9,500) 81,198,475        
Shares issued under equity line of credit $ 177 170,042 170,219
Shares issued under equity line of credit (in Shares)   1,774,650        
Shares issued for purchase of convertible note $ 20 76,811 76,831
Shares issued for purchase of convertible note (in Shares)   200,000        
Foreign currency translation adjustments 275 275
Cumulative dividend for Series A, D and F preferred stock (79,433) (79,433)
Net loss (11,986,754) (11,986,754)
Balance at Dec. 31, 2025 $ 11,287 $ 24,049,579 $ (36,800,876) $ (706) $ (12,740,716)
Balance (in Shares) at Dec. 31, 2025 5,000 112,852,596